Abstract
A small molecule inhibitor of β -secretase with a unique binding mode has been developed. Crystallographic determination of the enzyme–inhibitor complex shows the catalytic aspartate residues in the active site are not engaged in inhibitor binding. This unprecedented binding mode in the field of aspartyl protease inhibition is described.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have